# Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma

> **NCT02881125** · PHASE1 · COMPLETED · sponsor: **University of Washington** · enrollment: 2 (actual)

## Conditions studied

- Small Cell Carcinoma

## Interventions

- **DRUG:** Nortriptyline Hydrochloride
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT02881125
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-03
- **Primary completion:** 2018-01-01
- **Final completion:** 2019-11-30
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2019-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02881125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02881125, "Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02881125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*